Our data indicate that genetic variants of APOA-I and APOB SNPs play different roles in metabolic disorders, such as APOA-I rs9804646 decreased the risk of insulin resistance and MetS, but APOA-I rs888246 increased the risk of insulin resistance and MetS. This evidence concerns the gene APOB and metabolic syndrome.